导航延迟诱导病毒感染:治疗向和纳米粒子利用
Arathy Vasukutty1, Yeonwoo Jang2, Dongwan Han2
1Department of Biomedical Sciences and BioMedical Sciences Graduate Program (BMSGP), Chonnam National University Medical School, Jeollanam-do 58128, Republic of Korea.
Biomaterials research
|October 17, 2024
概括
病毒延迟是HIV和HPV等病毒的关键. 纳米技术提供了新的药物输送方式,可以消除这些潜在的感染,改善治疗结果.
科学领域:
- 病毒学和纳米技术
背景情况:
- 病毒延迟是病毒生存的关键机制,如疹病毒,艾滋病毒和HPV.
- 潜伏病毒存在于休眠状态 (表皮体或前病毒),逃避宿主防御,并对根除提出挑战.
- 病毒融入宿主DNA影响宿主-病原体动态和临床结果,特别是在艾滋病毒感染中.
研究的目的:
- 审查病毒潜伏的机制和消除潜伏病毒储存库的挑战.
- 探索基于纳米技术的干预措施对抗潜伏病毒感染的潜力.
- 突出纳米载体的进步,以有针对性地提供延迟逆转剂.
主要方法:
- 关于病毒延迟机制的科学文献的综述.
- 探索表观遗传和遗传干预策略.
- 对纳米技术应用的分析,包括纳米粒子和脂质体,用于药物输送,基因编辑和疫苗接种.
主要成果:
- 纳米载体 (纳米颗粒,脂质体) 显示出精确传递延迟逆转剂的潜力,克服生物障碍并实现持续释放.
- 纳米技术平台为潜在的病毒感染提供了有针对性,高效和多功能的治疗策略.
- 基于脂质,聚合物和无机纳米颗粒的进步对于开发新型抗病毒疗法至关重要.
结论:
- 将对病毒延迟的洞察力与纳米技术进步相结合,为新的治疗干预提供了一个有希望的途径.
- 基于纳米技术的策略具有巨大的潜力,用于管理持续性病毒感染,如神经HIV/AIDS,疹和HPV.
- 这种方法预示着在治疗慢性病毒性疾病方面开启了一个新时代,通过有效地准潜伏的储存库.
相关概念视频
Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Human Virome
The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...


